Prevalance of Celiac Disease in Patients with Inflammatory Bowel Disease in Turkish Population

Table 2

The clinical characteristics of patients with celiac disease and IBD.

Gender/age	IBD type/involvement	IBD duration/time between CD diagnosis and IBD diagnosis (years)	Therapy	Anti-TTG IGA (RU/ML)	Anti-EMA IGA (dilution)	Marsh score	Endoscopic findings
Female/38	CrD/distal colon involvement	9/8	5-ASA, methyl prednisolone, AZA	20.20	1/32-1/100	3c	Bulbus and duodenum 2nd segment appear pale, edematous, atrophic, comb tooth appearance
Female/56	CrD/terminal ileum	11/11	5-ASA	<2	1/10-1/32	3b	Normal appearing duodenum
Female/77	UC/distal colitis	3/1	5-ASA	55.87	1/320-1/1000	2	Duodenum 2nd segment has comb sign
Female/31	CrD/perianal fistula, colon involvement	23/1	5-ASA, methyl prednisolone, azathioprine	125.04	1/320-1/1000	3b	Duodenum 2nd segment has comb tooth appearance

IBD: inflammatory bowel disease; CrD: Crohn’s disease; UC: ulcerative colitis; CD: celiac disease; 5-ASA: 5 acetyl salicylic acid; AZA: azathioprine; RU/ML: relative unit/millilitre; anti-TTG: anti-tissue transglutaminase; anti-EMA: antiendomysium.